Kyle Andrews is an analyst in the chemistry lab at CSL Behring, a company that develops, manufactures and markets biotherapies used to treat serious and rare conditions. He has been accepted to the College of Pharmacy at Roosevelt University.
Kyle Andrews is an analyst in the chemistry lab at CSL Behring, a company that develops, manufactures and markets biotherapies used to treat serious and rare conditions. He has been accepted to the College of Pharmacy at Roosevelt University.